Evidence map›Paper›PMID 34899623›Full record

ArticleFrontiers in microbiology2021

A Novel Multidrug Resistant, Non-Tn

Luis Janssen, Felipe Marques de Almeida, Thais Amanda Silva Damasceno, Rodrigo de Paula Baptista, Georgios Joannis Pappas, Tatiana Amabile de Campos, Vicente de Paulo Martins

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Dissemination ofEmerging microbes & infections · 2026
    Article
  2. Review
  3. Monitoring Multi-Drug ResistantInfection and drug resistance · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Luis JanssenDepartment of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Brasília, Brazil.
Felipe Marques de AlmeidaDepartment of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Brasília, Brazil.
Thais Amanda Silva DamascenoDepartment of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Brasília, Brazil.
Rodrigo de Paula BaptistaCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States.
Georgios Joannis PappasDepartment of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Brasília, Brazil.
Tatiana Amabile de CamposDepartment of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Brasília, Brazil.
Vicente de Paulo MartinsDepartment of Cellular Biology, Institute of Biological Sciences, University of Brasilia, Brasília, Brazil.
Universidade de Brasília · BRUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is an increasing and urgent issue for human health worldwide, as it leads to the reduction of available antibiotics to treat bacterial infections, in turn increasing hospital stays and lethality. Therefore, the study and genomic surveillance of bacterial carriers of resistance in and outside of clinical settings is of utter importance. A colony of multidrug resistant (MDR) bacteria identified as

Indexed as

antimicrobial resistanceKlebsiella pneumoniaeMLSTone healthstrain typewater scarcity

Identifiers

PMID34899623
PMCPMC8654192
OpenAlexW3214972082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.